文献速递胰腺与胆道疾病消化道肿瘤与早癌消化内镜

突变谱与荧光原位杂交分析可提高胆管狭窄恶性病变的检出率

Mutation Profile and Fluorescence In Situ Hybridization Analyses Increase Detection of Malignancies in Biliary Strictures.
PubMed 文献 · Clin Gastroenterol Hepatol · 2016-12-23

这项前瞻性研究纳入107例连续接受内镜逆行胰胆管造影的胆管狭窄患者,最终分析100例,41%为恶性。常规细胞学灵敏度32%、特异度100%;联合荧光原位杂交(FISH)或突变谱(MP)分析后灵敏度升至51%(P<.01),三者联合灵敏度达73%(P<.001),特异度保持100%。作者认为FISH与MP互补,应在胆管狭窄诊断评估中序贯使用。

要点

  • 常规刷检细胞学检测胆管狭窄恶性病变灵敏度32%、特异度100%。
  • 细胞学联合FISH或MP分析灵敏度升至51%(P<.01),特异度未降低。
  • 细胞学、MP与FISH三者联合灵敏度达73%(P<.001),特异度100%。

核心结论

  • 在细胞学基础上加做FISH和突变分析可显著提高胆管狭窄恶性病变的检出灵敏度,特异度保持100%。
  • FISH与MP分析互补,作者认为应在胆管狭窄的诊断评估中序贯使用。

研究设计与样本

  • 前瞻性研究,纳入2012年6月至2014年6月因胆管狭窄接受内镜逆行胰胆管造影的107例连续患者,最终分析100例。
  • 对标准刷检采集的细胞行常规细胞学和FISH分析,对上清液行KRAS点突变及10个位点肿瘤抑制基因杂合性缺失的突变谱分析(MP分析在Interpace Diagnostics完成)。
  • 恶性狭窄依据后续活检或细胞学、手术标本病理或胆道恶性肿瘤死亡判定;良性狭窄依据术后12个月重复影像或实验室检查判定。
  • 采用精确二项检验确定FISH和MP检测恶性肿瘤的灵敏度和特异度。

主要发现

  • 最终分析100例患者中41%为胆道恶性肿瘤。
  • 细胞学检测恶性肿瘤的灵敏度为32%,特异度为100%。
  • 细胞学联合FISH或MP后灵敏度升至51%(P<.01),特异度未降低。
  • 细胞学、MP与FISH三者联合检测恶性肿瘤的灵敏度为73%(P<.001)。
  • 细胞学未检出的28例恶性肿瘤中,FISH额外检出9例,MP额外检出8例,FISH与MP合计检出17例。

临床怎么用

  • FISH和突变分析可使用内镜逆行胰胆管造影期间标准刷检采集的样本完成,突变可在样本上清液游离DNA中检出。
  • 作者认为FISH与MP分析互补,应在胆管狭窄的诊断评估中序贯使用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: It is a challenge to detect malignancies in biliary strictures. Various sampling methods are available to increase diagnostic yield, but these require additional procedure time and expertise. We evaluated the combined accuracy of fluorescence in situ hybridization (FISH) and polymerase chain reaction-based DNA mutation profiling (MP) of specimens collected using standard brush techniques. METHODS: We performed a prospective study of 107 consecutive patients treated for biliary strictures by endoscopic retrograde cholangiopancreatography from June 2012 through June 2014. We performed routine cytology and FISH analyses on cells collected by standard brush techniques, and analyzed supernatants for point mutations in KRAS and loss-of-heterozygosity mutations in tumor-suppressor genes at 10 loci (MP analysis was performed at Interpace Diagnostics). Strictures were determined to be nonmalignant based on repeat image analysis or laboratory test results 12 months after the procedure. Malignant strictures were identified based on subsequent biopsy or cytology analyses, pathology analyses of samples collected during surgery, or death from biliary malignancy. We determined the sensitivity and specificity with which FISH and MP analyses detected malignancies using the exact binomial test. RESULTS: Our final analysis included 100 patients; 41% had biliary malignancies. Cytology analysis identified patients with malignancies with 32% sensitivity and 100% specificity. Addition of FISH or MP results to cytology results increased the sensitivity of detection to 51% (P < .01) without reducing specificity. The combination of cytology, MP, and FISH analyses detected malignancies with 73% sensitivity (P < .001). FISH identified an additional 9 of the 28 malignancies not detected by cytology analysis, and MP identified an additional 8 malignancies. FISH and MP together identified 17 of the 28 malignancies not detected by cytology analysis. CONCLUSIONS: Addition of FISH and mutation analyses to cytology analysis significantly increased the level of sensitivity with which we detected malignancy in biliary strictures, with 100% specificity. These techniques can be performed using standard brush samples collected during endoscopic retrograde cholangiopancreatography, with mutations detected in free DNA in supernatant fluid of samples. The tests are complementary and therefore should be used sequentially in the diagnostic evaluation of biliary strictures.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Gonda TA, Viterbo D, Gausman V, et al. Mutation Profile and Fluorescence In Situ Hybridization Analyses Increase Detection of Malignancies in Biliary Strictures. Clin Gastroenterol Hepatol. 2016. PMID: 28017843. doi:10.1016/j.cgh.2016.12.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。